Onesource Specialty Pharma Limited — Important, 11-04-2025: General Updates

Onesource Specialty Pharma Limited has submitted reports from its Audit Committee and Independent Directors, confirming the compensation of shareholders eligible for fractional entitlements under the recent Scheme of Arrangement with Strides Pharma Science Limited and Steriscience Specialties Private Limited. The company has successfully compensated these shareholders who were entitled to fractional shares, following the guidelines set forth in the SEBI Master Circular. The fractional shares were sold at INR 1,275.04 per share, and the net proceeds were distributed proportionally to the eligible shareholders, adhering to tax deductions and incurred expenses. This development demonstrates the company’s compliance with regulatory mandates and its commitment to shareholder obligations, indicating a positive outlook for investor relations.